Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Cytopoint Plus is the first and only USDA-licensed next-generation mAb that provides 75 days of allergic itch relief in a single injection....

NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners, LP (“InTandem”) has been named to Inc.’s 2026 Founder-Friendly Investors list, which recognizes private equity firms, venture capital firms, and lenders with demonstrated track records of supporting founder-led companies. This year’s list recognizes InTandem among 14 designated healthcare specialist firms across the private equity investment landscape. The prestigious Founder-Friendly Investors list celebrates the investors and firms that wo...

AUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that management will participate in the following upcoming investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference Wednesday, November 11, 2026 1x1 investor meetings Boston, MA Jefferies Global Healthcare Conference in London Tuesday, November 17, 2026 Presentation at 8:30...

ST. JOHN’S, Newfoundland and Labrador--(BUSINESS WIRE)--Altius Minerals Corporation (TSX: ALS) (OTCQX: ATUSF) (“Altius”) announces that it has entered into a definitive agreement (the “Agreement”) with TNR Gold Corp. (TSXV: TNR) (“TNR”), pursuant to which Altius will acquire all of the issued and outstanding common shares of TNR that it does not already own by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia) (the “Transaction”). With this Transa...

LOCKHART, Texas--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) (“Oklo” or “the Company”), an advanced nuclear technology company, today announced the U.S. Department of Energy (DOE) has cleared the final operations hold point for the Groves Isotope Test Reactor (Groves-1), allowing the facility to advance into its research, testing, and training phase. With the facility cleared for unrestricted operations, Oklo will test its capabilities relevant to future isotope reactors and Oklo’s fast fission rea...

NEW YORK--(BUSINESS WIRE)--Eisen, the operating system for the full account lifecycle, today announced that Andrew Degler has joined the company as head of escheatment compliance. Degler has spent 17 years in unclaimed property, most recently with Wells Fargo, where he owned brokerage escheatment rules and co-owned the bank’s escheatment rules. He also co-managed third-party unclaimed property audits and served as one of the firm’s in-house experts on pending and enacted changes to unclaimed pr...

LONDON--(BUSINESS WIRE)--  USE OF THE DMO'S STANDING REPO FACILITY – 11 NOVEMBER 2026 Stock(s) made available to the market under DMO's Standing Repo Facility: Amount in GBP (nominal) Stock 66 million 0 1/8% Treasury Gilt 2028 (ISIN GB00BMBL1G81) In accordance with the terms of the DMO’s Standing Repo Facility, effective from 5 November 2026, the DMO has today created additional stock for Standing Repo purposes. The DMO has been given general collateral at the Bank of England's Official Bank Ra...